Scribd
Upload
493 views20 pages

Dr. Tonang Dwi Ardyanto, SP - PK (K), PH.D, FISQua

Tonang Dwi Ardyanto is a doctor and professor from Indonesia who has experience working in several countries. He has a PhD from Tottori University in Japan and is a specialist in clinical pathology. Currently he works as a lecturer at UNS, deputy director of service and education at a hospital, and is involved in several medical organizations. In this talk, he discusses concerns about future COVID variants, including whether they will cause severe disease, if vaccines will protect against new variants, and that the next variant may emerge from a handful of African countries.

Uploaded by

Mulyanti Yanthie
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
493 views20 pages

Dr. Tonang Dwi Ardyanto, SP - PK (K), PH.D, FISQua

Tonang Dwi Ardyanto is a doctor and professor from Indonesia who has experience working in several countries. He has a PhD from Tottori University in Japan and is a specialist in clinical pathology. Currently he works as a lecturer at UNS, deputy director of service and education at a hospital, and is involved in several medical organizations. In this talk, he discusses concerns about future COVID variants, including whether they will cause severe disease, if vaccines will protect against new variants, and that the next variant may emerge from a handful of African countries.

Uploaded by

Mulyanti Yanthie
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 20

Tonang Dwi Ardyanto

Pendidikan:
Dokter : S1 (UNS - 1999)
PhD : S2 leading to S3 (Tottori Univ Japan - 2006)
SpPK : PPDS PK UNS (2011), Konsultan (2021)
FISQua : ISQUA (2021)
Pengalaman LN : Singapore, Australia, Thailand, Perancis, Italia, Swiss, Vietnam

Pekerjaan/Afiliasi:
Dosen FK dan Pascasarjana UNS
Wakil Direktur Pelayanan dan Diklit (2015-2019) Wadir Diklit (2020-2023)
Bidang Organisasi Perhimpunan Dokter Spesialis Patologi Klinik (PDS Patlin) 2016-2019, 2020-2022
Kompartemen JKN Perhimpunan RS Indonesia (PERSI) 2016-2019, 2019-2022)
Bidang JKN Asosiasi RS Daerah (ARSADA) 2016-2019
Laboratorium Klinik Prodia 2011-sekarang
Konsultan PT Prodia Widyahusada 2020-2022
Konsultan UTD PMI Surakarta 2011-sekarang
Covid-19 Omicron:
Varian Baru dan Tantangan ke Depan
8 Juni 2022
Tonang Dwi Ardyanto, dr. SpPK-K, PhD, FISQua
FK/RS UNS, PDS Patklin, PERSI

Tonang Dwi Ardyanto


1.When will the next variant emerge
2.Will the next variant cause severe disease
3.Will vaccines protect againts new variants
S, N, and NSP12
(RdRP), present a
high mutational
range, but compared
to other RNA
viruses,
coronaviruses
present a low
mutational
frequency.
Focosi and Maggi, 2021

Clinical Microbiology Reviews Vol. 33, No. 4 2020

Tonang Dwi Ardyanto


Vaccines 2020, 8, 404;
doi:10.3390/vaccines8030404
Apakah Mutasi Selalu Merugikan Kita?

McGarty, Terrence. (2021). COVID-19: Mutations and Infectivity.


Journal of Advanced Research
26 (2020) 149–159
https://doi.org/10.1016/j.jare.2
020.08.002

Anal. Chem. 2020, 92, 10196−10209


Front. Cell. Infect. Microbiol. 11:781429.
January 2022
Beda Delta dan Omicron
I think we should be cautious in
extrapolating general rules from a
fairly short observation time frame
Where will the next coronavirus variant
of concern come from?

A handful of African countries are its


Feb 4th 2022
most likely source
The Complex of Covid-19 Patient Care

Front. Med. 8:615099. doi: 10.3389/fmed.2021.615099


Timelines and Future Targets
31 August 2021

Nat Rev Microbiol 19, 171–183 (2021). https:


//doi.org/10.1038/s41579-020-00461-z
Tonang Berbincang:
Tentang Covid Tonang Dwi Ardyanto

You might also like